Tag Archives: vaccine

Novavax COVID-19 vaccine, flu shot coadministration likely ‘viable strategy,’ company says

Maryland-based biotech company Novavax on Monday announced its experimental COVID-19 vaccine remained effective when coadministered with an approved flu shot. Researchers and drug makers are interested in studying coadministration and associated safety and efficacy, or giving multiple vaccines to a person during one visit, to ease logistics and help patients catch up on missed vaccinations,… Read More »

Why We Need to Discuss the COVID-19 Vaccine with Women of Childbearing Age

When we meet with women for perinatal psychiatry consultations, we now ask about vaccinations.  It’s not something we typically do, but after the last year, we are now getting involved in their decisions regarding vaccination against COVID-19.  Just as we counsel women to avoid alcohol and to consistently take their prenatal vitamins, providing information on… Read More »

COVID-19 fell quickest among seniors, CDC says, thanks to vaccine rollout

New data from the Centers for Disease Control and Prevention demonstrates the effectiveness of vaccines against the coronavirus, as incidents of COVID-19 fell the most among those targeted for vaccination early on in the campaign. In a new study, the CDC found that incidents of the disease fell for every age group beginning in January,… Read More »

Reaching vaccine targets is key to a return to mostly-normal life. But can the hesitant be swayed?

Breadcrumb Trail Links News Health Canada Will it take incentives to convince the 20 per cent of Canadian who appear to be sitting on the sidelines? Or coercive policies? Author of the article: Sharon Kirkey Publishing date: May 22, 2021  •  8 hours ago  •  5 minute read  •  65 Comments According to data, “vaccine willingness”… Read More »

Transparency by drug companies, scrutiny by journalists, vital in vaccine news

Pfizer’s chairman and CEO proclaimed in a Pfizer company news release: “Today is a great day for science and humanity.” In that PR news release – but only in that format – Pfizer announced early results of “a vaccine efficacy rate above 90%, at 7 days after the second dose.” That’s about all we know… Read More »